menu
    • menu

    Company profile for BioCryst Pharmaceuticals

    NEW Drugs in Dev: 12
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioCryst is a late-stage biotech company that is committed to delivering extraordinary medicines that help patients live ordinary lives. BioCryst has its headquarters in Durham, North Carolina and its Discovery Center of Excellence in Birmingham, Alabama. With expertise in drug discovery, clinical development, and regulatory affairs, we are advancing clinical programs and generating new compounds from our own discovery engine....
    BioCryst is a late-stage biotech company that is committed to delivering extraordinary medicines that help patients live ordinary lives. BioCryst has its headquarters in Durham, North Carolina and its Discovery Center of Excellence in Birmingham, Alabama. With expertise in drug discovery, clinical development, and regulatory affairs, we are advancing clinical programs and generating new compounds from our own discovery engine. We are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioCryst PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4505 Emperor Blvd., Suite 200 Durham, NC 27703
    Telephone
    Telephone
    (919) 859-1302
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biocryst.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biocryst-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/biocrystpharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioCryst Reports Full Year 2025 Results and Business Update
    BioCryst Reports Full Year 2025 Results and Business Update

    26 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/26/3245413/29446/en/BioCryst-Reports-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    26 Feb 2026
    Share Share
    BioCryst To Present At Upcoming Investor Conference
    BioCryst To Present At Upcoming Investor Conference

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239070/29446/en/BioCryst-to-Present-at-Upcoming-Investor-Conference.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Biocryst To Unveil ORLADEYO And Navenibart Data At AAAAI 2026
    Biocryst To Unveil ORLADEYO And Navenibart Data At AAAAI 2026

    11 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/11/3236119/29446/en/BioCryst-to-Present-New-HAE-Data-from-ORLADEYO-berotralstat-and-Navenibart-at-the-2026-American-Academy-of-Allergy-Asthma-Immunology-Annual-Meeting.html

    GLOBENEWSWIRE
    11 Feb 2026
    Share Share
    Biocryst Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
    Biocryst Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    05 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/05/3232843/29446/en/BioCryst-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Feb 2026
    Share Share
    BioCryst Reports Q4 2025 Financial Results
    BioCryst Reports Q4 2025 Financial Results

    05 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/05/3232853/29446/en/BioCryst-to-Report-Fourth-Quarter-2025-Financial-Results-on-February-26.html

    GLOBENEWSWIRE
    05 Feb 2026
    Share Share
    BioCryst Complete Acquisition Astria to Lead HAE Treatment
    BioCryst Complete Acquisition Astria to Lead HAE Treatment

    23 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/23/3224805/29446/en/BioCryst-Completes-Acquisition-of-Astria-Therapeutics-Expanding-Leadership-in-Hereditary-Angioedema.html

    GLOBENEWSWIRE
    23 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact BioCryst Pharmaceuticals and get a quotation

    BioCryst Pharmaceuticals is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find a price of Peramivir bulk offered by BioCryst Pharmaceuticals

    Find a price of Ulodesine Hydrochloride bulk offered by BioCryst Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search